Skip to content

Preventing Posttraumatic Osteoarthritis With Physical Activity Promotion

Preventing Posttraumatic Osteoarthritis With Physical Activity Promotion

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04906499
Enrollment
7
Registered
2021-05-28
Start date
2021-08-01
Completion date
2022-09-09
Last updated
2024-01-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anterior Cruciate Ligament Injuries, Exercise, Cartilage, Articular, Knee Injuries, Osteoarthritis, Osteoarthritis, Knee, Arthritis, Joint Diseases

Brief summary

Osteoarthritis (OA) is a leading cause of disability worldwide that affects millions of Americans each year. Posttraumatic OA (PTOA) significantly impacts patients after anterior cruciate ligament (ACL) injury and ACL reconstruction (ACLR) with approximately 50% of patients developing PTOA within 20 years of injury or surgery. Knee joint mechanical loading measured via physical activity (i.e. daily steps) is insufficient in individuals after ACLR compared to uninjured individuals. Establishing the beneficial effects of physical activity to promote optimal free-living knee joint mechanical loading and improve knee joint health will aid in the development of cost-effective interventions that prevent PTOA and health burden of the disease.

Detailed description

Osteoarthritis (OA) is a leading cause of disability worldwide resulting in severe limitations in daily activities and chronic pain. It is estimated that 35% of posttraumatic OA (PTOA) cases occur after knee injuries and surgeries such as anterior cruciate ligament (ACL) injury and ACL reconstruction (ACLR). Optimal free-living mechanical loading, which refers to the forces acting on the knee caused by daily activities, plays an essential role in maintaining knee articular cartilage health. After ACLR, individuals take fewer steps per day as compared to uninjured controls. This results in insufficient free-living mechanical loading to joint tissues and is associated with early PTOA development. Adequate physical activity (PA) is recommended to help reduce risk of PTOA, but it is unclear how changes in PA acutely impact knee joint cartilage health. The overall objective of this pretest-posttest experimental pilot study is to determine how optimizing free-living mechanical loading through PA promotion improves cartilage composition in individuals who demonstrate insufficient free-living mechanical loading after ACLR. PA promotion will be delivered over 8 weeks using commercially available PA monitors and the patients' smartphone to provide daily personalized and achievable step goals to increase daily step counts to a level consistent with healthy PA participation. The hypothesis for aim 1 is that MRI markers of proteoglycan density associated with PTOA development will improve after 8-weeks of PA promotion exposure. Hypothesis for aim 2 is that greater changes in steps per day will be associated with improved proteoglycan density. Change in MRI markers of proteoglycan density and steps per day will be assessed using a pretest-posttest design in 8 adults who are 6 months to 5 years post-ACLR with insufficient mechanical loading (\<8,000 steps per day)24 and suboptimal quality of life (quality of life survey\<87.5). Outcomes will be collected before (pretest) and after (posttest) 8-weeks of PA promotion. For the PA promotion, participants will receive a text message each morning with a personalized, daily step count goal and a link used to confirm receipt of the goal. The preceding 10 days of step data will be rank ordered and the 60th percentile step count will be set as the goal for the next day. The proposed work is innovative, in that this study will use a novel combination of outcomes that will lead to unprecedented insight into the influence of PA promotion in mitigating early PTOA development.

Interventions

After enrolling, participants will be outfitted with a Fitbit Charge 2 activity monitor. The monitor will be worn during all waking hours, and compliance will be considered as a day with ≥ 1,000 steps. Participants will complete a 14-day run-in observation period while wearing the Fitbit but no PA promotion will occur. Individuals who are noncompliant during the run in period (\<10 days with \<1,000 steps) will be removed. Participants will receive a text message each morning with a personalized, daily step count goal and a link used to confirm receipt of the goal. The preceding 10 days of step data will be rank ordered and the 60th percentile step count will be set as the goal for the next day.

Sponsors

North Carolina Translational and Clinical Sciences Institute
CollaboratorOTHER
University of North Carolina, Chapel Hill
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 35 Years
Healthy volunteers
No

Inclusion criteria

Participants will be included if they: * Provide informed consent and sign a HIPPA form prior to any study procedures are performed * Have completed all other formal physical therapy and therapeutic exercise regimens, and will not be engaging in any other formal therapy for their ACLR during the study * Are between the ages of 18 and 35. * Underwent an ACLR no earlier than 6 months and no later than 5 years prior to enrollment. * Demonstrate \< 8,000 steps per day during the screening phase of the study as assessed using the Actigraph GT9X Link monitor. * Demonstrate clinically relevant-knee symptoms, defined as a Knee Injury and Osteoarthritis Outcomes Score (KOOS) quality of life subscale \< 72.2

Exclusion criteria

Participants will be excluded if: * The participant underwent an ACLR revision surgery due to a previous ACL graft injury. * Multiple ligament surgery was indicated at the time of ACLR surgery. * A lower extremity fracture was suffered during the ACL injury. * The participant has been diagnosed with osteoarthritis in either knee * They have a cochlear implant, metal in body, claustrophobia, or history of seizures.

Design outcomes

Primary

MeasureTime frameDescription
Change in T1rho Relaxation Times in the Lateral Tibial Condylepre-intervention (baseline), post-intervention (~8 weeks)change in MRI marker of T1rho relaxation times of lateral tibial articular cartilage (i.e proteoglycan density) from pre-intervention (baseline) to approximately 8-weeks after physical activity promotion intervention
Change in T1rho Relaxation Times in the Medial Femoral Condylepre-intervention (baseline), post-intervention (~8 weeks)Change in MRI marker of T1rho relaxation times of medial femoral articular cartilage (i.e proteoglycan density) from pre-intervention (baseline) to approximately 8-weeks after physical activity promotion intervention
Change in T1rho Relaxation Times in the Medial Tibial Condylepre-intervention (baseline), post-intervention (~8 weeks)Change in MRI marker of T1rho relaxation times of medial tibial articular cartilage (i.e proteoglycan density) from pre-intervention (baseline) to approximately 8-weeks after physical activity promotion intervention
Change in T1rho Relaxation Times in the Lateral Femoral Condylepre-intervention (baseline), post-intervention (~8 weeks)change in MRI marker of T1rho relaxation times of lateral femoral articular cartilage (i.e proteoglycan density) from pre-intervention (baseline) to approximately 8-weeks after physical activity promotion intervention
T1rho Relaxation Times in the Lateral Femoral Condyle Post-interventionpost-intervention (~8 weeks)MRI marker of T1rho relaxation times of lateral femoral articular cartilage (i.e proteoglycan density) at post-intervention (\ 8 weeks)
T1rho Relaxation Times in the Medial Femoral Condyle at Baselinepre-intervention (baseline)MRI marker of T1rho relaxation times of medial femoral articular cartilage (i.e proteoglycan density) at pre-intervention (baseline)
T1rho Relaxation Times in the Medial Femoral Condyle Post-interventionpost-intervention (~8 weeks)MRI marker of T1rho relaxation times of medial femoral articular cartilage (i.e proteoglycan density) at post-intervention (\ 8 weeks)
T1rho Relaxation Times in the Lateral Femoral Condyle at Baselinepre-intervention (baseline)MRI marker of T1rho relaxation times of lateral femoral articular cartilage (i.e., proteoglycan density) at pre-intervention (baseline)
T1rho Relaxation Times in the Medial Tibial Condyle at Baselinepre-intervention (baseline)MRI marker of T1rho relaxation times of medial tibial articular cartilage (i.e proteoglycan density) at pre-intervention (baseline)
T1rho Relaxation Times in the Medial Tibial Condyle Post-interventionpost-intervention (~8 weeks)MRI marker of T1rho relaxation times of medial tibial articular cartilage (i.e proteoglycan density) at post-intervention (\ 8 weeks)
T1rho Relaxation Times in the Lateral Tibial Condyle at Baselinepre-intervention (baseline)MRI marker of T1rho relaxation times of lateral tibial articular cartilage (i.e proteoglycan density) at pre-intervention (baseline)
T1rho Relaxation Times in the Lateral Tibial Condyle Post-interventionpost-intervention (~8 weeks)MRI marker of T1rho relaxation times of lateral tibial articular cartilage (i.e proteoglycan density) at post-intervention (\ 8 weeks)
Change in Daily Stepspre-intervention (baseline), post-intervention (~8 weeks)Change in average steps per day over 7 day physical activity monitor wear pre-intervention (baseline) to approximately 8-weeks after physical activity promotion intervention

Secondary

MeasureTime frameDescription
Knee Injury and Osteoarthritis Outcome Score Quality of Life Subscalepre-intervention (baseline)Knee injury Osteoarthritis Outcome Score (KOOS) Quality of Life subscale to measure knee-related quality of life at pre-intervention (baseline). A higher score indicates better knee-related quality of life. Min = 0 and Max = 100

Other

MeasureTime frameDescription
Percentage of Days Participant is Compliant With Fitbit Monitor Wear (>1,000 Steps Per Day)up to post-intervention (~8 weeks)physical activity promotion intervention compliance
Percentage of Patients Retained at Post-intervention Visit (~8 Weeks) Physical Activity Promotion Intervention Retentionpost-intervention (~8 weeks)physical activity promotion intervention retention

Countries

United States

Participant flow

Participants by arm

ArmCount
Physical Activity Promotion Group
Participants will receive a text message each morning with a personalized, daily step count goal and a link used to confirm receipt of the goal. The preceding 10 days of step data will be rank ordered and the 60th percentile step count will be set as the goal for the next day. Physical Activity Promotion: After enrolling, participants will be outfitted with a Fitbit Charge 2 activity monitor. The monitor will be worn during all waking hours, and compliance will be considered as a day with ≥ 1,000 steps. Participants will complete a 14-day run-in observation period while wearing the Fitbit but no PA promotion will occur. Individuals who are noncompliant during the run in period (\<10 days with \<1,000 steps) will be removed. Participants will receive a text message each morning with a personalized, daily step count goal and a link used to confirm receipt of the goal. The preceding 10 days of step data will be rank ordered and the 60th percentile step count will be set as the goal for the next day.
7
Total7

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyLack of time1

Baseline characteristics

CharacteristicPhysical Activity Promotion Group
Age, Continuous25.7 years
STANDARD_DEVIATION 5.8
Ethnicity (NIH/OMB)
Hispanic or Latino
0 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
7 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
2 Participants
Race (NIH/OMB)
Black or African American
0 Participants
Race (NIH/OMB)
More than one race
1 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
White
4 Participants
Region of Enrollment
United States
7 Participants
Sex: Female, Male
Female
6 Participants
Sex: Female, Male
Male
1 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 7
other
Total, other adverse events
0 / 7
serious
Total, serious adverse events
0 / 7

Outcome results

Primary

Change in Daily Steps

Change in average steps per day over 7 day physical activity monitor wear pre-intervention (baseline) to approximately 8-weeks after physical activity promotion intervention

Time frame: pre-intervention (baseline), post-intervention (~8 weeks)

ArmMeasureValue (MEAN)Dispersion
Physical Activity Promotion GroupChange in Daily Steps2054 steps/dayStandard Deviation 3795
Primary

Change in T1rho Relaxation Times in the Lateral Femoral Condyle

change in MRI marker of T1rho relaxation times of lateral femoral articular cartilage (i.e proteoglycan density) from pre-intervention (baseline) to approximately 8-weeks after physical activity promotion intervention

Time frame: pre-intervention (baseline), post-intervention (~8 weeks)

ArmMeasureValue (MEAN)Dispersion
Physical Activity Promotion GroupChange in T1rho Relaxation Times in the Lateral Femoral Condyle-0.81 msStandard Deviation 1.91
95% CI: [-0.88, 0.71]
Primary

Change in T1rho Relaxation Times in the Lateral Tibial Condyle

change in MRI marker of T1rho relaxation times of lateral tibial articular cartilage (i.e proteoglycan density) from pre-intervention (baseline) to approximately 8-weeks after physical activity promotion intervention

Time frame: pre-intervention (baseline), post-intervention (~8 weeks)

ArmMeasureValue (MEAN)Dispersion
Physical Activity Promotion GroupChange in T1rho Relaxation Times in the Lateral Tibial Condyle-1.18 msStandard Deviation 1.22
95% CI: [-0.87, 0.73]
Primary

Change in T1rho Relaxation Times in the Medial Femoral Condyle

Change in MRI marker of T1rho relaxation times of medial femoral articular cartilage (i.e proteoglycan density) from pre-intervention (baseline) to approximately 8-weeks after physical activity promotion intervention

Time frame: pre-intervention (baseline), post-intervention (~8 weeks)

ArmMeasureValue (MEAN)Dispersion
Physical Activity Promotion GroupChange in T1rho Relaxation Times in the Medial Femoral Condyle-0.50 msStandard Deviation 3.71
95% CI: [-0.67, 0.9]
Primary

Change in T1rho Relaxation Times in the Medial Tibial Condyle

Change in MRI marker of T1rho relaxation times of medial tibial articular cartilage (i.e proteoglycan density) from pre-intervention (baseline) to approximately 8-weeks after physical activity promotion intervention

Time frame: pre-intervention (baseline), post-intervention (~8 weeks)

ArmMeasureValue (MEAN)Dispersion
Physical Activity Promotion GroupChange in T1rho Relaxation Times in the Medial Tibial Condyle-1.11 msStandard Deviation 1.31
95% CI: [-0.48, 0.94]
Primary

T1rho Relaxation Times in the Lateral Femoral Condyle at Baseline

MRI marker of T1rho relaxation times of lateral femoral articular cartilage (i.e., proteoglycan density) at pre-intervention (baseline)

Time frame: pre-intervention (baseline)

ArmMeasureValue (MEAN)Dispersion
Physical Activity Promotion GroupT1rho Relaxation Times in the Lateral Femoral Condyle at Baseline51.40 msStandard Deviation 2.69
Primary

T1rho Relaxation Times in the Lateral Femoral Condyle Post-intervention

MRI marker of T1rho relaxation times of lateral femoral articular cartilage (i.e proteoglycan density) at post-intervention (\ 8 weeks)

Time frame: post-intervention (~8 weeks)

ArmMeasureValue (MEAN)Dispersion
Physical Activity Promotion GroupT1rho Relaxation Times in the Lateral Femoral Condyle Post-intervention50.60 msStandard Deviation 2.48
95% CI: [-0.44, 1.24]
Primary

T1rho Relaxation Times in the Lateral Tibial Condyle at Baseline

MRI marker of T1rho relaxation times of lateral tibial articular cartilage (i.e proteoglycan density) at pre-intervention (baseline)

Time frame: pre-intervention (baseline)

ArmMeasureValue (MEAN)Dispersion
Physical Activity Promotion GroupT1rho Relaxation Times in the Lateral Tibial Condyle at Baseline51.69 msStandard Deviation 4.92
Primary

T1rho Relaxation Times in the Lateral Tibial Condyle Post-intervention

MRI marker of T1rho relaxation times of lateral tibial articular cartilage (i.e proteoglycan density) at post-intervention (\ 8 weeks)

Time frame: post-intervention (~8 weeks)

ArmMeasureValue (MEAN)Dispersion
Physical Activity Promotion GroupT1rho Relaxation Times in the Lateral Tibial Condyle Post-intervention50.51 msStandard Deviation 4.36
95% CI: [-0.05, 1.93]
Primary

T1rho Relaxation Times in the Medial Femoral Condyle at Baseline

MRI marker of T1rho relaxation times of medial femoral articular cartilage (i.e proteoglycan density) at pre-intervention (baseline)

Time frame: pre-intervention (baseline)

ArmMeasureValue (MEAN)Dispersion
Physical Activity Promotion GroupT1rho Relaxation Times in the Medial Femoral Condyle at Baseline53.48 msStandard Deviation 4.58
Primary

T1rho Relaxation Times in the Medial Femoral Condyle Post-intervention

MRI marker of T1rho relaxation times of medial femoral articular cartilage (i.e proteoglycan density) at post-intervention (\ 8 weeks)

Time frame: post-intervention (~8 weeks)

ArmMeasureValue (MEAN)Dispersion
Physical Activity Promotion GroupT1rho Relaxation Times in the Medial Femoral Condyle Post-intervention52.98 msStandard Deviation 3.23
95% CI: [-0.68, 0.93]
Primary

T1rho Relaxation Times in the Medial Tibial Condyle at Baseline

MRI marker of T1rho relaxation times of medial tibial articular cartilage (i.e proteoglycan density) at pre-intervention (baseline)

Time frame: pre-intervention (baseline)

ArmMeasureValue (MEAN)Dispersion
Physical Activity Promotion GroupT1rho Relaxation Times in the Medial Tibial Condyle at Baseline54.48 msStandard Deviation 3.62
Primary

T1rho Relaxation Times in the Medial Tibial Condyle Post-intervention

MRI marker of T1rho relaxation times of medial tibial articular cartilage (i.e proteoglycan density) at post-intervention (\ 8 weeks)

Time frame: post-intervention (~8 weeks)

ArmMeasureValue (MEAN)Dispersion
Physical Activity Promotion GroupT1rho Relaxation Times in the Medial Tibial Condyle Post-intervention53.38 msStandard Deviation 3.03
95% CI: [-0.13, 1.77]
Secondary

Knee Injury and Osteoarthritis Outcome Score Quality of Life Subscale

Knee injury Osteoarthritis Outcome Score (KOOS) Quality of Life subscale to measure knee-related quality of life at pre-intervention (baseline). A higher score indicates better knee-related quality of life. Min = 0 and Max = 100

Time frame: pre-intervention (baseline)

ArmMeasureValue (MEAN)Dispersion
Physical Activity Promotion GroupKnee Injury and Osteoarthritis Outcome Score Quality of Life Subscale63.5 score on a scaleStandard Deviation 22.5
Secondary

Knee Injury and Osteoarthritis Outcome Score Quality of Life Subscale

Knee injury Osteoarthritis Outcome Score Quality of Life subscale (KOOS) Quality of Life subscale to measure knee-related quality of life at post-intervention. A higher score indicates better knee-related quality of life. Min = 0 and Max = 100

Time frame: post-intervention (~8 weeks)

ArmMeasureValue (MEAN)Dispersion
Physical Activity Promotion GroupKnee Injury and Osteoarthritis Outcome Score Quality of Life Subscale69.8 score on a scaleStandard Deviation 25.4
95% CI: [-1.24, 0.44]
Other Pre-specified

Percentage of Days Participant is Compliant With Fitbit Monitor Wear (>1,000 Steps Per Day)

physical activity promotion intervention compliance

Time frame: up to post-intervention (~8 weeks)

ArmMeasureValue (MEAN)Dispersion
Physical Activity Promotion GroupPercentage of Days Participant is Compliant With Fitbit Monitor Wear (>1,000 Steps Per Day)98.00 percent of daysStandard Deviation 0.02
Other Pre-specified

Percentage of Patients Retained at Post-intervention Visit (~8 Weeks) Physical Activity Promotion Intervention Retention

physical activity promotion intervention retention

Time frame: post-intervention (~8 weeks)

ArmMeasureValue (NUMBER)
Physical Activity Promotion GroupPercentage of Patients Retained at Post-intervention Visit (~8 Weeks) Physical Activity Promotion Intervention Retention86 percentage of participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026